Picture of DURECT logo

DRRX DURECT Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapMomentum Trap

Annual cashflow statement for DURECT, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-20.6-0.582-36.3-35.3-27.6
Depreciation
Non-Cash Items3.03-10.43.032.88-8.16
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital28.4-28-4.366.061.34
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities11.1-38.7-37.3-26.3-34.4
Capital Expenditures-0.155-0.208-0.194-0.111-0.052
Purchase of Fixed Assets
Other Investing Cash Flow Items-27.29.6415.519.9-1.11
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-27.39.4315.319.8-1.17
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities19.515.750.50.08320.5
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash3.28-13.628.5-6.36-15.1